# A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury

> **NCT00638053** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 100 (estimated)

## Conditions studied

- Brain Injuries
- Growth Hormone Deficiency Dwarfism

## Interventions

- **GENETIC:** somatropin

## Key facts

- **NCT ID:** NCT00638053
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-11
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 100 (ESTIMATED)
- **Why stopped:** See reason for termination in detailed description.
- **Last updated:** 2008-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638053, "A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00638053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*